Differential Bicistronic Gene Translation Mediated by the Internal Ribosome Entry Site Element of Encephalomyocarditis Virus

Overview

Journal Biomed J

Publisher Elsevier

Specialty General Medicine

Date 2022 Jun 24

PMID 35747995

Authors

Chia-Rui Shen

Ya-Shan Chen

Yih-Shiou Hwang

Hsi-Jien Chen

Chao-Lin Liu

Affiliations

Soon will be listed here.

Abstract

Background: Internal ribosome entry sites (IRESs) allow the translation of a transcript independent of its cap structure. They are distributed in some viruses and cellular RNA. The element is applied in dual gene expression in a single vector. Although it appears the lower efficiency of IRES-mediated translation than that of cap-dependent translation, it is with the crucial needs to know the precise differences in translational efficacy between upstream cistrons (cap-dependent) and downstream cistrons (IRES-mediate, cap-independent) before applying the bicistronic vector in biomedical applications.

Methods: This study aimed to provide real examples and showed the precise differences for translational efficiency dependent upon target gene locations. We generated various bicistronic constructs with quantifiable reporter genes as upstream and downstream cistrons of the encephalomyocarditis virus (EMCV) IRES to precisely evaluate the efficacy of IRES-mediated translation in mammalian cells.

Results: There was no significant difference in protein production when the reporter gene was cloned as an upstream cistron. However, lower levels of protein production were obtained when the reporter gene was located downstream of the IRES. Moreover, in the presence of an upstream cistron, a markedly reduced level of protein production was observed.

Conclusion: Our findings demonstrate the version of the EMCV IRES that is provided in many commercial vectors is relatively less efficient than cap-dependent translation and provide valuable information regarding the utilization of IRES to facilitate the expression of more than one protein from a transcript.

Citing Articles

Selectively expressed RNA molecules as a versatile tool for functionalized cell targeting.

Rastfeld F, Hoffmann M, Kruger S, Bohn P, Gribling-Burrer A, Wagner L Nat Commun. 2025; 16(1):420.

PMID: 39762287 PMC: 11704337. DOI: 10.1038/s41467-024-55547-6.

One day at a time.

Kattner A Biomed J. 2022; 44(6 Suppl 1):S1-S7.

PMID: 35042016 PMC: 8760849. DOI: 10.1016/j.bj.2022.01.009.

References

Delluc-Clavieres A, Le Bec C, Van den Berghe L, Conte C, Allo V, Danos O . Efficient gene transfer in skeletal muscle with AAV-derived bicistronic vector using the FGF-1 IRES. Gene Ther. 2008; 15(15):1090-8. DOI: 10.1038/gt.2008.49. View

Sugimoto Y, Aksentijevich I, Murray G, Brady R, Pastan I, Gottesman M . Retroviral coexpression of a multidrug resistance gene (MDR1) and human alpha-galactosidase A for gene therapy of Fabry disease. Hum Gene Ther. 1995; 6(7):905-15. DOI: 10.1089/hum.1995.6.7-905. View

Pao W, Klimstra D, Fisher G, Varmus H . Use of avian retroviral vectors to introduce transcriptional regulators into mammalian cells for analyses of tumor maintenance. Proc Natl Acad Sci U S A. 2003; 100(15):8764-9. PMC: 166387. DOI: 10.1073/pnas.1133333100. View

Rees S, Coote J, Stables J, Goodson S, Harris S, Lee M . Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques. 1996; 20(1):102-4, 106, 108-10. DOI: 10.2144/96201st05. View

Scheidemann F, Therrien J, Pfutzner W . Selectable bicistronic vectors in skin gene therapy. Arch Dermatol Res. 2008; 300(8):415-23. DOI: 10.1007/s00403-008-0878-6. View

Vagner S, Galy B, Pyronnet S . Irresistible IRES. Attracting the translation machinery to internal ribosome entry sites. EMBO Rep. 2001; 2(10):893-8. PMC: 1084086. DOI: 10.1093/embo-reports/kve208. View

Jang S, Krausslich H, Nicklin M, Duke G, Palmenberg A, Wimmer E . A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol. 1988; 62(8):2636-43. PMC: 253694. DOI: 10.1128/JVI.62.8.2636-2643.1988. View

Hellen C, Sarnow P . Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev. 2001; 15(13):1593-612. DOI: 10.1101/gad.891101. View

Komar A, Hatzoglou M . Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J Biol Chem. 2005; 280(25):23425-8. DOI: 10.1074/jbc.R400041200. View

10.

Brasey A, Lopez-Lastra M, Ohlmann T, Beerens N, Berkhout B, Darlix J . The leader of human immunodeficiency virus type 1 genomic RNA harbors an internal ribosome entry segment that is active during the G2/M phase of the cell cycle. J Virol. 2003; 77(7):3939-49. PMC: 150645. DOI: 10.1128/jvi.77.7.3939-3949.2003. View

11.

Fussenegger M, Moser S, Mazur X, Bailey J . Autoregulated multicistronic expression vectors provide one-step cloning of regulated product gene expression in mammalian cells. Biotechnol Prog. 1997; 13(6):733-40. DOI: 10.1021/bp970108r. View

12.

Allera-Moreau C, Delluc-Clavieres A, Castano C, Van Den Berghe L, Golzio M, Moreau M . Long term expression of bicistronic vector driven by the FGF-1 IRES in mouse muscle. BMC Biotechnol. 2007; 7:74. PMC: 2180170. DOI: 10.1186/1472-6750-7-74. View

13.

Gray N, Wickens M . Control of translation initiation in animals. Annu Rev Cell Dev Biol. 1999; 14:399-458. DOI: 10.1146/annurev.cellbio.14.1.399. View

14.

Hennecke M, Kwissa M, Metzger K, Oumard A, Kroger A, Schirmbeck R . Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs. Nucleic Acids Res. 2001; 29(16):3327-34. PMC: 55851. DOI: 10.1093/nar/29.16.3327. View

15.

Edelstein M, Abedi M, Wixon J, Edelstein R . Gene therapy clinical trials worldwide 1989-2004-an overview. J Gene Med. 2004; 6(6):597-602. DOI: 10.1002/jgm.619. View

16.

Bedard K, Semler B . Regulation of picornavirus gene expression. Microbes Infect. 2004; 6(7):702-13. DOI: 10.1016/j.micinf.2004.03.001. View

17.

Creancier L, Morello D, Mercier P, Prats A . Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J Cell Biol. 2000; 150(1):275-81. PMC: 2185555. DOI: 10.1083/jcb.150.1.275. View

18.

Moser S, Rimann M, Fux C, Schlatter S, Bailey J, Fussenegger M . Dual-regulated expression technology: a new era in the adjustment of heterologous gene expression in mammalian cells. J Gene Med. 2002; 3(6):529-49. DOI: 10.1002/jgm.219. View

19.

Thomas C, Ehrhardt A, Kay M . Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet. 2003; 4(5):346-58. DOI: 10.1038/nrg1066. View

20.

Zhou W, Edelman G, Mauro V . A positive feedback vector for identification of nucleotide sequences that enhance translation. Proc Natl Acad Sci U S A. 2005; 102(18):6273-8. PMC: 1088366. DOI: 10.1073/pnas.0409892102. View